{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T16:44:51Z","timestamp":1769705091936,"version":"3.49.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-05681-7","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T03:19:45Z","timestamp":1769656785000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Up-regulated miR-4443 Holds Diagnostic Significance for Parkinson\u2019s Disease and may be Involved in Neuroinflammation"],"prefix":"10.1007","volume":"63","author":[{"given":"Huijie","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenwu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siying","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuyao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"issue":"5","key":"5681_CR1","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","volume":"20","author":"E Tolosa","year":"2021","unstructured":"Tolosa E, Garrido A, Scholz SW, Poewe W (2021) Challenges in the diagnosis of Parkinson\u2019s disease. Lancet Neurol 20(5):385\u2013397","journal-title":"Lancet Neurol"},{"key":"5681_CR2","doi-asserted-by":"publisher","first-page":"e080952","DOI":"10.1136\/bmj-2024-080952","volume":"388","author":"D Su","year":"2025","unstructured":"Su D, Cui Y, He C, Yin P, Bai R, Zhu J et al (2025) Projections for prevalence of Parkinson\u2019s disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021. BMJ 388:e080952","journal-title":"BMJ"},{"issue":"6","key":"5681_CR3","first-page":"1","volume":"82","author":"RP Munhoz","year":"2024","unstructured":"Munhoz RP, Tumas V, Pedroso JL, Silveira-Moriyama L (2024) The clinical diagnosis of Parkinson\u2019s disease. Arq Neuropsiquiatr 82(6):1\u201310","journal-title":"Arq Neuropsiquiatr"},{"issue":"10","key":"5681_CR4","doi-asserted-by":"publisher","first-page":"4413","DOI":"10.1016\/j.asjsur.2023.04.087","volume":"46","author":"X Min","year":"2023","unstructured":"Min X, Zhou W, Fan X (2023) Risk factors for Parkinson\u2019s disease in aging population. Asian J Surg 46(10):4413\u20134415","journal-title":"Asian J Surg"},{"key":"5681_CR5","doi-asserted-by":"publisher","first-page":"1168539","DOI":"10.3389\/fimmu.2023.1168539","volume":"14","author":"A Nott","year":"2023","unstructured":"Nott A, Holtman IR (2023) Genetic insights into immune mechanisms of Alzheimer\u2019s and Parkinson\u2019s disease. Front Immunol 14:1168539","journal-title":"Front Immunol"},{"issue":"8","key":"5681_CR6","doi-asserted-by":"publisher","first-page":"4148","DOI":"10.3390\/ijms23084148","volume":"23","author":"T-W Liu","year":"2022","unstructured":"Liu T-W, Chen C-M, Chang K-H (2022) Biomarker of neuroinflammation in Parkinson\u2019s Disease. Int J Mol Sci 23(8):4148","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5681_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02496-w","volume":"19","author":"A Heidari","year":"2022","unstructured":"Heidari A, Yazdanpanah N, Rezaei N (2022) The role of toll-like receptors and neuroinflammation in Parkinson\u2019s disease. J Neuroinflammation 19(1):135","journal-title":"J Neuroinflammation"},{"issue":"10423","key":"5681_CR8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","volume":"403","author":"Y Ben-Shlomo","year":"2024","unstructured":"Ben-Shlomo Y, Darweesh S, Llibre-Guerra J, Marras C, Luciano MS, Tanner C (2024) The epidemiology of Parkinson\u2019s disease. Lancet (London, England) 403(10423):283\u2013292","journal-title":"Lancet (London, England)"},{"issue":"4","key":"5681_CR9","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/s43587-025-00818-0","volume":"5","author":"Y-H Gan","year":"2025","unstructured":"Gan Y-H, Ma L-Z, Zhang Y, You J, Guo Y, He Y et al (2025) Large-scale proteomic analyses of incident Parkinson\u2019s disease reveal new pathophysiological insights and potential biomarkers. Nat Aging 5(4):642\u2013657","journal-title":"Nat Aging"},{"key":"5681_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-0716-2823-2_1","volume":"2595","author":"A Vishnoi","year":"2023","unstructured":"Vishnoi A, Rani S (2023) MiRNA biogenesis and regulation of diseases: an updated overview. Methods in Molecular Biology (Clifton, NJ) 2595:1\u201312","journal-title":"Methods in Molecular Biology (Clifton, NJ)"},{"key":"5681_CR11","doi-asserted-by":"publisher","first-page":"116899","DOI":"10.1016\/j.biopha.2024.116899","volume":"177","author":"Z Alkhazaali-Ali","year":"2024","unstructured":"Alkhazaali-Ali Z, Sahab-Negah S, Boroumand AR, Tavakol-Afshari J (2024) MicroRNA (miRNA) as a biomarker for diagnosis, prognosis, and therapeutics molecules in neurodegenerative disease. Biomed Pharmacother 177:116899","journal-title":"Biomed Pharmacother"},{"key":"5681_CR12","doi-asserted-by":"crossref","unstructured":"Duan X, Zheng Q, Liang L Zhou L (2024) Serum exosomal miRNA-125b and miRNA-451a are potential diagnostic biomarker for Alzheimer's diseases. Degener Neurol Neuromuscul Dis 14:21\u201331","DOI":"10.2147\/DNND.S444567"},{"issue":"8","key":"5681_CR13","doi-asserted-by":"publisher","first-page":"5404","DOI":"10.1007\/s12035-023-03862-2","volume":"61","author":"M Mohammadinasr","year":"2024","unstructured":"Mohammadinasr M, Montazersaheb S, Ayromlou H, Hosseini V, Molavi O, Hejazi MS (2024) Exosome content-mediated signaling pathways in multiple sclerosis. Mol Neurobiol 61(8):5404\u20135417","journal-title":"Mol Neurobiol"},{"key":"5681_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2024.156624","author":"M Mohammadinasr","year":"2024","unstructured":"Mohammadinasr M, Montazersaheb S, Hosseini V, Kahroba H, Talebi M, Molavi O et al (2024) Epstein-barr virus-encoded BART9 and BART15 miRNAs are elevated in exosomes of cerebrospinal fluid from relapsing-remitting multiple sclerosis patients. Cytokine","journal-title":"Cytokine"},{"issue":"16","key":"5681_CR15","doi-asserted-by":"publisher","first-page":"e2322924121","DOI":"10.1073\/pnas.2322924121","volume":"121","author":"K-H Kim","year":"2024","unstructured":"Kim K-H, Hong EP, Lee Y, McLean ZL, Elezi E, Lee R et al (2024) Posttranscriptional regulation of FAN1 by miR-124-3p at rs3512 underlies onset-delaying genetic modification in Huntington\u2019s disease. Proc Natl Acad Sci U S A 121(16):e2322924121","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"5681_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-024-00791-2","volume":"10","author":"N Shaheen","year":"2024","unstructured":"Shaheen N, Shaheen A, Osama M, Nashwan AJ, Bharmauria V, Flouty O (2024) Micrornas regulation in Parkinson\u2019s disease, and their potential role as diagnostic and therapeutic targets. NPJ Parkinsons Dis 10(1):186","journal-title":"NPJ Parkinsons Dis"},{"issue":"24","key":"5681_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252413260","volume":"25","author":"JS Hwang","year":"2024","unstructured":"Hwang JS, Kim SG, George NP, Kwon M, Jang YE, Lee SS et al (2024) Biological function analysis of microRNAs and proteins in the cerebrospinal fluid of patients with Parkinson\u2019s disease. Int J Mol Sci 25(24):13260","journal-title":"Int J Mol Sci"},{"issue":"6","key":"5681_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/cells10061410","volume":"10","author":"BL Santos-Lobato","year":"2021","unstructured":"Santos-Lobato BL, Vidal AF, Ribeiro-Dos-Santos \u00c2 (2021) Regulatory miRNA-mRNA networks in Parkinson\u2019s disease. Cells 10(6):1410","journal-title":"Cells"},{"issue":"4","key":"5681_CR19","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s11011-020-00546-x","volume":"35","author":"X Yang","year":"2020","unstructured":"Yang X, Zhang M, Wei M, Wang A, Deng Y, Cao H (2020) Microrna-216a inhibits neuronal apoptosis in a cellular Parkinson\u2019s disease model by targeting Bax. Metab Brain Dis 35(4):627\u2013635","journal-title":"Metab Brain Dis"},{"key":"5681_CR20","doi-asserted-by":"crossref","unstructured":"Zhang L, Chen X, Chang M Jiao B (2021) MiR-30c-5p\/ATG5 Axis Regulates the Progression of Parkinson's Disease. Front Cell Neurosci 15:644507","DOI":"10.3389\/fncel.2021.644507"},{"issue":"10","key":"5681_CR21","doi-asserted-by":"publisher","first-page":"e70342","DOI":"10.1111\/ejn.70342","volume":"62","author":"S Shukla","year":"2025","unstructured":"Shukla S, Goyani S, Chakraborty D, Saranga MV, Mane M, Chandak N et al (2025) hsa-miR-22-3p-Mediated exosome release from neurons induces apoptosis in recipient glial and neuronal cells in parkinson\u2019s disease stress conditions. Eur J Neurosci 62(10):e70342","journal-title":"Eur J Neurosci"},{"issue":"12","key":"5681_CR22","doi-asserted-by":"publisher","first-page":"110912","DOI":"10.1016\/j.jbc.2025.110912","volume":"301","author":"S Vaheb Hosseinabadi","year":"2025","unstructured":"Vaheb Hosseinabadi S, Tahamtan H, Mahmoudian Esfahani M, Ghaedi-Heidari R, Hashemi M-S, Peymani M et al (2025) Upregulation of miR-361-5p attenuates MPP+-induced neurotoxicity in dopaminergic SH-SY5Y cells as Parkinson\u2019s disease model. J Biol Chem 301(12):110912","journal-title":"J Biol Chem"},{"key":"5681_CR23","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.freeradbiomed.2017.10.379","volume":"115","author":"V Calabrese","year":"2018","unstructured":"Calabrese V, Santoro A, Monti D, Crupi R, Di Paola R, Latteri S et al (2018) Aging and Parkinson\u2019s disease: inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis. Free Radic Biol Med 115:80\u201391","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"5681_CR24","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1007\/s10753-024-02125-z","volume":"48","author":"MJ Saadh","year":"2025","unstructured":"Saadh MJ, Muhammad FA, Singh A, Mustafa MA, Al Zuhairi RAH, Ghildiyal P et al (2025) MicroRNAs modulating neuroinflammation in Parkinson\u2019s disease. Inflammation 48(3):1042\u20131062","journal-title":"Inflammation"},{"issue":"3","key":"5681_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-025-01568-z","volume":"40","author":"Z Moradi Vastegani","year":"2025","unstructured":"Moradi Vastegani Z, Ghaedi-Heidari R, Oroujalian A, Peymani M, Ghaedi K (2025) Manuscript title: unravelling the neuroprotective role of miR-27a-3p in the MAPK pathway in Parkinson\u2019s disease. Metab Brain Dis 40(3):141","journal-title":"Metab Brain Dis"},{"issue":"6","key":"5681_CR26","doi-asserted-by":"publisher","first-page":"14770","DOI":"10.1080\/21655979.2022.2109807","volume":"13","author":"Y Mao","year":"2022","unstructured":"Mao Y, Shen J, Wu Y, Wenjing R, Zhu F, Duan S (2022) Aberrant expression of microrna-4443 (miR-4443) in human diseases. Bioengineered 13(6):14770\u201314779","journal-title":"Bioengineered"},{"issue":"8","key":"5681_CR27","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1111\/ene.14282","volume":"27","author":"S Li","year":"2020","unstructured":"Li S, Lu G, Wang D, He JL, Zuo L, Wang H et al (2020) MicroRNA-4443 regulates monocyte activation by targeting tumor necrosis factor receptor associated factor 4 in stroke-induced immunosuppression. Eur J Neurol 27(8):1625\u20131637","journal-title":"Eur J Neurol"},{"key":"5681_CR28","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.3389\/fimmu.2017.01440","volume":"8","author":"Y Qi","year":"2017","unstructured":"Qi Y, Zhou Y, Chen X, Ye L, Zhang Q, Huang F et al (2017) MicroRNA-4443 causes CD4+ T cells dysfunction by targeting TNFR-Associated factor 4 in Graves\u2019 disease. Front Immunol 8:1440","journal-title":"Front Immunol"},{"issue":"7","key":"5681_CR29","doi-asserted-by":"publisher","first-page":"511","DOI":"10.2174\/1567205019666220805120303","volume":"19","author":"X Ge","year":"2022","unstructured":"Ge X, Yao T, Zhang C, Wang Q, Wang X, Xu L-C (2022) Human microRNA-4433 (hsa-miR-4443) targets 18 genes to be a risk factor of neurodegenerative diseases. Curr Alzheimer Research. 19(7):511\u2013522","journal-title":"Curr Alzheimer Research."},{"issue":"1","key":"5681_CR30","doi-asserted-by":"publisher","first-page":"712","DOI":"10.3390\/ijms24010712","volume":"24","author":"M Salemi","year":"2022","unstructured":"Salemi M, Marchese G, Lanza G, Cosentino FII, Salluzzo MG, Schillaci FA et al (2022) Role and dysregulation of miRNA in patients with Parkinson\u2019s disease. Int J Mol Sci 24(1):712","journal-title":"Int J Mol Sci"},{"issue":"12","key":"5681_CR31","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W et al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30(12):1591\u20131601","journal-title":"Mov Disord"},{"issue":"2","key":"5681_CR32","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s12017-021-08676-w","volume":"24","author":"X Lin","year":"2022","unstructured":"Lin X, Wang R, Li R, Tao T, Zhang D, Qi Y (2022) Diagnostic performance of miR-485\u20133p in patients with Parkinson\u2019s Disease and its Relationship with Neuroinflammation. Neuromolecular Medicine. 24(2):195\u2013201","journal-title":"Neuromolecular Medicine."},{"key":"5681_CR33","doi-asserted-by":"crossref","unstructured":"Yao L, Ye Y, Mao H, Lu F, He X, Lu G et al (2018) MicroRNA-124 regulates the expression of MEKK3 in the inflammatory pathogenesis of Parkinson\u2019s disease. J Neuroinflammation 15(1):13","DOI":"10.1186\/s12974-018-1053-4"},{"issue":"5","key":"5681_CR34","first-page":"933","volume":"17","author":"RC Silva","year":"2021","unstructured":"Silva RC, Domingues HS, Salgado AJ, Teixeira FG (2021) From regenerative strategies to pharmacological approaches: can we fine-tune treatment for Parkinson\u2019s disease? Neural Regeneration Research. 17(5):933\u2013936","journal-title":"Neural Regeneration Research."},{"issue":"3","key":"5681_CR35","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00702-024-02865-0","volume":"132","author":"A Giannakis","year":"2025","unstructured":"Giannakis A, Sioka C, Kloufetou E, Konitsiotis S (2025) Cognitive impairment in Parkinson\u2019s disease and other parkinsonian syndromes. J Neul Transmiss (Vienna, Austria: 1996) 132(3):341\u2013355","journal-title":"J Neul Transmiss (Vienna, Austria: 1996)"},{"issue":"10","key":"5681_CR36","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1001\/jamaneurol.2021.1312","volume":"78","author":"T Mitchell","year":"2021","unstructured":"Mitchell T, Leh\u00e9ricy S, Chiu SY, Strafella AP, Stoessl AJ, Vaillancourt DE (2021) Emerging neuroimaging biomarkers across disease stage in Parkinson Disease: A Review. JAMA eurology 78(10):1262\u20131272","journal-title":"JAMA eurology"},{"issue":"11","key":"5681_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1808","volume":"10","author":"C-H Park","year":"2020","unstructured":"Park C-H, Lee PH, Lee S-K, Chung SJ, Shin N-Y (2020) The diagnostic potential of multimodal neuroimaging measures in Parkinson\u2019s disease and atypical parkinsonism. Brain Behav 10(11):e01808","journal-title":"Brain Behav"},{"issue":"4","key":"5681_CR38","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41582-022-00618-9","volume":"18","author":"J-Y Lee","year":"2022","unstructured":"Lee J-Y, Martin-Bastida A, Murueta-Goyena A, Gabilondo I, Cuenca N, Piccini P et al (2022) Multimodal brain and retinal imaging of dopaminergic degeneration in Parkinson disease. Nat Rev Neurol 18(4):203\u2013220","journal-title":"Nat Rev Neurol"},{"key":"5681_CR39","doi-asserted-by":"crossref","unstructured":"Vlaar AMM, van Kroonenburgh MJPG, Kessels AGH, Weber WE (2007) Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes. BMC Neurol 7(1):27","DOI":"10.1186\/1471-2377-7-27"},{"issue":"1","key":"5681_CR40","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1038\/s41598-022-06663-0","volume":"12","author":"P-E Papathoma","year":"2022","unstructured":"Papathoma P-E, Markaki I, Tang C, Lilja Lindstr\u00f6m M, Savitcheva I, Eidelberg D et al (2022) A replication study, systematic review and meta-analysis of automated image-based diagnosis in parkinsonism. Sci Rep 12(1):2763","journal-title":"Sci Rep"},{"issue":"4","key":"5681_CR41","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/s41596-022-00787-3","volume":"18","author":"L Concha-Marambio","year":"2023","unstructured":"Concha-Marambio L, Pritzkow S, Shahnawaz M, Farris CM, Soto C (2023) Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluid. Nature Protocols 18(4):1179\u20131196","journal-title":"Nature Protocols"},{"key":"5681_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2022.10.007","author":"D Yoo","year":"2022","unstructured":"Yoo D, Bang J-I, Ahn C, Nyaga VN, Kim Y-E, Kang MJ et al (2022) Diagnostic value of \u03b1-synuclein seeding amplification assays in \u03b1-synucleinopathies: a systematic review and meta-analysis. Parkinsonism Relat Disord","journal-title":"Parkinsonism Relat Disord"},{"issue":"15","key":"5681_CR43","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1001\/jama.2024.0792","volume":"331","author":"CH Gibbons","year":"2024","unstructured":"Gibbons CH, Levine T, Adler C, Bellaire B, Wang N, Stohl J et al (2024) Skin biopsy detection of phosphorylated \u03b1-Synuclein in patients with Synucleinopathies. JAMA 331(15):1298\u20131306","journal-title":"JAMA"},{"issue":"12","key":"5681_CR44","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsab172","volume":"44","author":"MG Miglis","year":"2021","unstructured":"Miglis MG, Zitser J, Schneider L, During E, Jaradeh S, Freeman R et al (2021) Cutaneous \u03b1-synuclein is correlated with autonomic impairment in isolated rapid eye movement sleep behavior disorder. Sleep. 44(12):zsab172","journal-title":"Sleep."},{"issue":"4","key":"5681_CR45","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1007\/s00415-023-12093-3","volume":"271","author":"HB Taha","year":"2024","unstructured":"Taha HB, Bogoniewski A (2024) Analysis of biomarkers in speculative CNS-enriched extracellular vesicles for parkinsonian disorders: a comprehensive systematic review and diagnostic meta-analysis. J Neurol 271(4):1680\u20131706","journal-title":"J Neurol"},{"issue":"5","key":"5681_CR46","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00401-023-02557-1","volume":"145","author":"S Dutta","year":"2023","unstructured":"Dutta S, Hornung S, Taha HB, Bitan G (2023) Biomarkers for parkinsonian disorders in CNS-originating EVs: promise and challenges. Acta Neuropathol 145(5):515\u2013540","journal-title":"Acta Neuropathol"},{"issue":"2","key":"5681_CR47","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/mds.1062","volume":"16","author":"B Holmberg","year":"2001","unstructured":"Holmberg B, Kallio M, Johnels B, Elam M (2001) Cardiovascular reflex testing contributes to clinical evaluation and differential diagnosis of parkinsonian syndromes. Movement Disorders: Official Journal of the Movement Disorder Society 16(2):217\u2013225","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"1","key":"5681_CR48","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.74.1.56","volume":"74","author":"DE Riley","year":"2003","unstructured":"Riley DE, Chelimsky TC (2003) Autonomic nervous system testing may not distinguish multiple system atrophy from Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 74(1):56\u201360","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"14","key":"5681_CR49","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.3390\/cells12141911","volume":"12","author":"S Malhotra","year":"2023","unstructured":"Malhotra S, Miras MCM, Pappolla A, Montalban X, Comabella M (2023) Liquid biopsy in neurological diseases. Cells 12(14):1911","journal-title":"Cells"},{"issue":"2","key":"5681_CR50","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/jcp.30932","volume":"238","author":"A Elangovan","year":"2023","unstructured":"Elangovan A, Venkatesan D, Selvaraj P, Pasha MY, Babu HWS, Iyer M et al (2023) miRNA in Parkinson\u2019s disease: From pathogenesis to theranostic approaches. J Cell Physiol 238(2):329\u2013354","journal-title":"J Cell Physiol"},{"issue":"15","key":"5681_CR51","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1021\/acschemneuro.5c00313","volume":"16","author":"S Vijayakumar","year":"2025","unstructured":"Vijayakumar S, Yesudhason BV, Anandharaj JL, Kalaivanan L, Selvan Christyraj JRS (2025) Exosomes and their miRNA as a potential biomarker in the diagnosis of Parkinson\u2019s disease. ACS Chem Neurosci 16(15):2756\u20132766","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"5681_CR52","doi-asserted-by":"publisher","first-page":"15268","DOI":"10.1038\/s41598-021-94734-z","volume":"11","author":"Q Chen","year":"2021","unstructured":"Chen Q, Deng N, Lu K, Liao Q, Long X, Gou D et al (2021) Elevated plasma miR-133b and miR-221-3p as biomarkers for early Parkinson\u2019s disease. Sci Rep 11(1):15268","journal-title":"Sci Rep"},{"issue":"13","key":"5681_CR53","doi-asserted-by":"publisher","first-page":"6348","DOI":"10.1111\/jcmm.16612","volume":"25","author":"M Baghi","year":"2021","unstructured":"Baghi M, Yadegari E, Rostamian Delavar M, Peymani M, Ganjalikhani-Hakemi M, Salari M et al (2021) MiR-193b deregulation is associated with Parkinson\u2019s disease. J Cell Mol Med 25(13):6348\u20136360","journal-title":"J Cell Mol Med"},{"key":"5681_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.865139","author":"L Wu","year":"2022","unstructured":"Wu L, Xu Q, Zhou M, Chen Y, Jiang C, Jiang Y et al (2022) Plasma miR-153 and miR-223 levels as potential biomarkers in Parkinson\u2019s disease. Front Neurosci","journal-title":"Front Neurosci"},{"issue":"18","key":"5681_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/cells11182908","volume":"11","author":"B Ara\u00fajo","year":"2022","unstructured":"Ara\u00fajo B, Caridade-Silva R, Soares-Guedes C, Martins-Macedo J, Gomes ED, Monteiro S et al (2022) Neuroinflammation and Parkinson\u2019s disease-from neurodegeneration to therapeutic opportunities. Cells 11(18):2908","journal-title":"Cells"},{"issue":"9","key":"5681_CR56","doi-asserted-by":"publisher","first-page":"4676","DOI":"10.3390\/ijms22094676","volume":"22","author":"K Badanjak","year":"2021","unstructured":"Badanjak K, Fixemer S, Smaji\u0107 S, Skupin A, Gr\u00fcnewald A (2021) The contribution of microglia to neuroinflammation in Parkinson\u2019s disease. Int J Mol Sci 22(9):4676","journal-title":"Int J Mol Sci"},{"issue":"7","key":"5681_CR57","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.3390\/cells12071012","volume":"12","author":"S Isik","year":"2023","unstructured":"Isik S, Yeman Kiyak B, Akbayir R, Seyhali R, Arpaci T (2023) Microglia mediated neuroinflammation in Parkinson\u2019s disease. Cells 12(7):1012","journal-title":"Cells"},{"issue":"1","key":"5681_CR58","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12974-023-02762-5","volume":"20","author":"D He","year":"2023","unstructured":"He D, Fu S, Ye B, Wang H, He Y, Li Z et al (2023) Activation of HCA2 regulates microglial responses to alleviate neurodegeneration in LPS-induced in vivo and in vitro models. J Neuroinflammation 20(1):86","journal-title":"J Neuroinflammation"},{"key":"5681_CR59","doi-asserted-by":"crossref","unstructured":"Ignatius E, Puosi R, Palom\u00e4ki M, Forsbom N, Pohjanpelto M, Alitalo T et al (2022) Duplication\/triplication mosaicism of EBF3 and expansion of the EBF3 neurodevelopmental disorder phenotype. Eur J Paediatr Neurol 37:1\u20137","DOI":"10.1016\/j.ejpn.2021.12.012"},{"issue":"4","key":"5681_CR60","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s12031-018-1129-8","volume":"65","author":"J Li","year":"2018","unstructured":"Li J, Sun Y, Chen J (2018) Identification of critical genes and miRNAs associated with the development of Parkinson\u2019s disease. J Mol Neurosci 65(4):527\u2013535","journal-title":"J Mol Neurosci"},{"key":"5681_CR61","doi-asserted-by":"crossref","unstructured":"Hu W, Wang M, Sun G, Zhang L, Lu H (2024) Early B Cell Factor 3 (EBF3) attenuates Parkinson's disease through directly regulating contactin-associated protein-like 4 (CNTNAP4) transcription: an experimental study. Cell Signal 118:111139","DOI":"10.1016\/j.cellsig.2024.111139"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05681-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-05681-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05681-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T04:58:45Z","timestamp":1769662725000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-05681-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5681"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-05681-7","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"30 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Baotou Central Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"404"}}